These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2965799

  • 1. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.
    Moyes C, Milne A.
    N Z Med J; 1988 Apr 13; 101(843):162-4. PubMed ID: 2965799
    [Abstract] [Full Text] [Related]

  • 2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR, Bosley A, Woodfield DG.
    N Z Med J; 1989 Jan 25; 102(860):1-3. PubMed ID: 2521527
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S, Yoshida K, Sato T, Shimada H, Deguchi T.
    Hepatogastroenterology; 1990 Dec 25; 37 Suppl 2():140-4. PubMed ID: 2150664
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Reactivity and immunogenicity of Engerix B, the recombinant DNA vaccine against hepatitis B].
    Borcić B, Gasparović V, Mihaljevic I, Aleraj B, Margan IG.
    Acta Med Iugosl; 1989 Dec 25; 43(4):247-54. PubMed ID: 2534021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R, Koren R, Bass D.
    Isr Med Assoc J; 2001 May 25; 3(5):328-32. PubMed ID: 11411195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S, Jirapongsa A, Lokaphadhana K.
    Southeast Asian J Trop Med Public Health; 1991 Mar 25; 22(1):39-40. PubMed ID: 1835140
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of Engerix-B in healthy Malaysian medical students.
    Isahak I, Abdul Malik Y, Hakim AS, Baharin R.
    Singapore Med J; 1990 Aug 25; 31(4):314-6. PubMed ID: 2147781
    [Abstract] [Full Text] [Related]

  • 11. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
    Just M, Berger R, Just V.
    Postgrad Med J; 1987 Aug 25; 63 Suppl 2():121-3. PubMed ID: 3317346
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
    Schiff GM, Sherwood JR, Zeldis JB, Krause DS.
    J Adolesc Health; 1995 Jan 25; 16(1):12-7. PubMed ID: 7742331
    [Abstract] [Full Text] [Related]

  • 13. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P, Deciron F, Tortey E, Barin F, Chiron JP, Yvonnet B, Diouf C, Denis F, Diop-Mar I, Correa P.
    IARC Sci Publ; 1984 Jan 25; (63):319-35. PubMed ID: 6242150
    [Abstract] [Full Text] [Related]

  • 14. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital.
    Catania G, Di Ciommo V, Concato C.
    Recenti Prog Med; 1996 Jun 25; 87(6):271-4. PubMed ID: 8766952
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity, reactogenicity and comparison of two doses of recombinant DNA yeast-derived hepatitis B vaccine in Ethiopian children.
    Tsega E, Tafesse B, Horton J, Nordenfelt E, Wolde-Hawariat G, Hansson BG, Lindberg J.
    Trop Geogr Med; 1991 Jun 25; 43(1-2):220-7. PubMed ID: 1836290
    [Abstract] [Full Text] [Related]

  • 16. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP.
    Pediatrics; 2007 Aug 25; 120(2):e373-81. PubMed ID: 17636112
    [Abstract] [Full Text] [Related]

  • 17. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A, Moyes CD, Dimitrakakis M.
    N Z Med J; 1988 Jun 08; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS, Raut SK, Patki PS, Phadke MA, Jadhav SS, Kapre SV, Dhorje SP, Godse SR.
    Vaccine; 2006 Apr 24; 24(17):3457-60. PubMed ID: 16530299
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.
    Vaccine; 2005 Jul 01; 23(31):4082-7. PubMed ID: 15963363
    [Abstract] [Full Text] [Related]

  • 20. [Immune response to hepatitis B vaccine produced with genetic engineering].
    Ramón Torrell JM, Micheo Salas C, Cerdó Goicouria C, Casas García I, Escribá Jordana JM.
    Rev Clin Esp; 1991 Feb 01; 188(2):68-71. PubMed ID: 2041902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.